James Godwin Reporting
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned healthcare providers and the public about the circulation of counterfeit versions of VISITECT HIV Advanced Disease Test Kits in Nigeria.
This alert was disclosed in a public notice published on the agency’s official website on Wednesday, March 4, 2026.
Recall that NAFDAC first issued a formal statement on the counterfeit HIV test kits in February 2026, before issuing this reminder. The latest alert, designated as Public Alert No. 011/2026, confirmed that counterfeit and parallel-imported unregistered versions of the test kits have been identified in the country.
According to NAFDAC, the VISITECT CD4 Advanced Disease assay is a rapid diagnostic test used to identify patients with severe HIV infection. The instrument-free test can detect low CD4 levels in approximately 40 minutes using blood samples. It is commonly used in resource-limited healthcare settings to determine which patients require urgent treatment.
The Marketing Authorization Holder of the product, EURO SPECS International Nigeria Limited, has confirmed the existence of counterfeit or parallel-imported versions being distributed through unauthorized channels.
NAFDAC warned that falsified or unregistered medical products pose serious risks, as they have not been evaluated for quality, safety, or effectiveness.
The agency also highlighted key discrepancies between the genuine and counterfeit versions of the product.
